Literature DB >> 15523355

Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.

Nanette B Silverberg1, Peggy Lin, Lisa Travis, Jeanne Farley-Li, Anthony J Mancini, Annette M Wagner, Sarah L Chamlin, Amy S Paller.   

Abstract

BACKGROUND: Vitiligo is an autoimmune disorder characterized by loss of pigmentation. Phototherapy and application of topical corticosteroids are most commonly prescribed. However, these therapies are often not effective and use of corticosteroids on the face may lead to cutaneous atrophy, telangiectasia, and ocular complications.
OBJECTIVE: We sought to assess the efficacy of topical tacrolimus ointment in the treatment of pediatric vitiligo.
METHODS: A retrospective review was performed of 57 pediatric patients with vitiligo at two clinical sites. Patients were treated with tacrolimus ointment for at least 3 months. Clinical responses were documented during clinic visits, and by pretacrolimus and posttacrolimus photography.
RESULTS: At least partial response was noted to tacrolimus ointment on the head and neck in 89%, and on the trunk and extremities in 63% of patients. Facial vitiligo of the segmental type showed the best response rate. Two patients initially experienced burning on application.
CONCLUSIONS: Topical tacrolimus ointment is an effective alternative therapy for childhood vitiligo, particularly involving the head and neck.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523355     DOI: 10.1016/j.jaad.2004.05.036

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  [Methods and means for pigmentation and depigmentation. Sense or nonsense?].

Authors:  V Hegyi; J Hegyi
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

Review 2.  Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.

Authors:  Dene Simpson; Stuart Noble
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Epidermal permeability barrier recovery is delayed in vitiligo-involved sites.

Authors:  J Liu; W Y Man; C Z Lv; S P Song; Y J Shi; P M Elias; M Q Man
Journal:  Skin Pharmacol Physiol       Date:  2010-02-25       Impact factor: 3.479

4.  Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients.

Authors:  Lu-Mei Wang; Wan-Jiao Lu; Jing-Tao Yuan; Bi-Bing Zeng; Dan Li; Feng Zhang; Jun-Jie Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

5.  [Off-label indications for topical tacrolimus].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 6.  Current Management of Pediatric Vitiligo.

Authors:  Freya Van Driessche; Nanette Silverberg
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

Review 7.  Vitiligo in children.

Authors:  Talia Kakourou
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

8.  Effect of 0.1% tacrolimus ointment in localized vitiligo: an open uncontrolled trial.

Authors:  K Bhuvana; N Sarala; Gurcharan Singh; T N Kumar
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

9.  Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy.

Authors:  Kanika Sahni; Vishal Gupta; Neena Khanna
Journal:  Indian Dermatol Online J       Date:  2014-04

10.  Childhood vitiligo: treatment paradigms.

Authors:  Amrinder Jit Kanwar; M Sendhil Kumaran
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.